D'ANDREA, MARCO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 7.897
AS - Asia 4.130
EU - Europa 2.945
SA - Sud America 515
AF - Africa 281
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.859
Nazione #
US - Stati Uniti d'America 7.690
SG - Singapore 1.349
IT - Italia 989
CN - Cina 606
BR - Brasile 400
HK - Hong Kong 397
RU - Federazione Russa 393
IE - Irlanda 317
DE - Germania 282
GB - Regno Unito 234
IN - India 217
JP - Giappone 198
VN - Vietnam 197
IR - Iran 175
PK - Pakistan 157
SA - Arabia Saudita 150
BD - Bangladesh 144
FR - Francia 129
CA - Canada 128
KR - Corea 111
FI - Finlandia 86
NL - Olanda 82
AU - Australia 79
TR - Turchia 79
ES - Italia 71
EG - Egitto 60
IQ - Iraq 59
MX - Messico 58
ZA - Sudafrica 56
PL - Polonia 55
PH - Filippine 50
ID - Indonesia 44
NG - Nigeria 42
CZ - Repubblica Ceca 38
CH - Svizzera 36
JO - Giordania 36
AT - Austria 35
SE - Svezia 35
AR - Argentina 34
MY - Malesia 33
ET - Etiopia 32
TH - Thailandia 31
BE - Belgio 27
UA - Ucraina 27
TW - Taiwan 25
DK - Danimarca 23
CL - Cile 22
NP - Nepal 21
CO - Colombia 17
EC - Ecuador 16
GH - Ghana 15
MA - Marocco 14
RO - Romania 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
GR - Grecia 11
PE - Perù 11
DZ - Algeria 10
HU - Ungheria 10
KE - Kenya 10
NO - Norvegia 10
TN - Tunisia 10
LT - Lituania 8
RS - Serbia 8
NZ - Nuova Zelanda 7
PT - Portogallo 7
SN - Senegal 7
VE - Venezuela 7
AL - Albania 6
CR - Costa Rica 6
CI - Costa d'Avorio 5
GE - Georgia 5
PY - Paraguay 5
UZ - Uzbekistan 5
ER - Eritrea 4
HN - Honduras 4
LY - Libia 4
EE - Estonia 3
JM - Giamaica 3
MO - Macao, regione amministrativa speciale della Cina 3
MW - Malawi 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CY - Cipro 2
EU - Europa 2
KG - Kirghizistan 2
QA - Qatar 2
SI - Slovenia 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
Totale 15.839
Città #
Wilmington 916
Singapore 785
Houston 763
San Jose 719
Ashburn 562
Fairfield 491
Chandler 471
Woodbridge 379
Hong Kong 306
Dublin 282
Beijing 252
Council Bluffs 234
Rome 212
Medford 202
Seattle 192
Cambridge 165
New York 165
The Dalles 139
Jeddah 132
Los Angeles 126
Ann Arbor 123
Tokyo 121
Lawrence 92
Santa Clara 90
Lauterbourg 73
São Paulo 70
Milan 67
Hanoi 66
Helsinki 66
Ho Chi Minh City 61
Buffalo 53
Moscow 53
Frankfurt am Main 50
Munich 50
Dallas 47
San Diego 47
London 46
Hamburg 41
Seoul 38
Cairo 37
Philadelphia 36
Amman 35
Lahore 34
Redwood City 34
Toronto 33
Warsaw 32
Orem 31
Atlanta 30
Prague 29
Central 28
Chennai 28
Jakarta 27
Minneapolis 27
Nuremberg 27
Tehran 27
Chicago 26
Florence 26
Berlin 25
Brooklyn 24
Chuo 22
Montreal 22
Redondo Beach 22
Delhi 21
Melbourne 21
Menlo Park 21
Naples 21
Calgary 20
Mumbai 20
New Delhi 20
Sydney 20
Columbus 19
Istanbul 18
Denver 17
Johannesburg 17
Manchester 17
Phoenix 17
Santiago 17
Amsterdam 16
Birmingham 16
Bologna 16
Des Moines 16
Madrid 16
Shanghai 16
Vienna 16
Karachi 15
Bangkok 14
Copenhagen 14
Durban 14
Falls Church 14
Knoxville 14
Nanjing 14
North Bergen 14
Rio de Janeiro 14
San Francisco 14
Turin 14
Addis Ababa 13
Guangzhou 13
Kochi 13
Miami 13
Norwalk 13
Totale 10.027
Nome #
Fighting multi-drug resistant Klebsiella pneumoniae by using lytic phages 698
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 670
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 586
φbO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage 484
First report of multi-drug resistant, VEB-6 producing Proteus mirabilis isolates from Italy 450
Draft genome sequence of the agarase-producing Sphingomonas sp. MCT13 400
Genetic linkage of optrA and cfr, integrated into an unconventional circularisable structure, in Enterococcus faecium 359
Chromosomal Integration of blaKPC-2 in Proteus mirabilis Clinical Isolates 339
MCT13: a newly discovered agarase-producing Sphingomonas sp. Isolated from freshwaters 322
Sphingomonas turrisvirgatae a new agar-degrading Sphingomonas species 322
Isolation and characterization of lytic bacteriophages targeting major multi-drug resistant high-risk clones of carbapenemase-producing Klebsiella pneumoniae 298
Isolation and characterisation of vB_Kpn_F48, a novel bacteriophage for Klebsiella pneumoniae 295
Tn6349: a novel cfr- and poxtA-carrying transposon of enterococcal origin in a linezolid-resistant MRSA 295
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101 285
The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains 283
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 238
The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance 220
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: Increasing diversity with predominance of the ST512 clade II sublineage 195
Sphingomonas turrisvirgatae sp. nov., an agar-degrading species isolated from freshwater. 194
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 187
SELECTION AND CHARACTERISATION OF PHAGES ABLE TO DEGRADE BIOFILM PRODUCED BY CLINICAL ISOLATES OF E. FAECALIS 182
Italian nationwide survey on pseudomonas aeruginosa from invasive infections: Activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 178
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms 172
The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages 171
Evidence of another anthropic impact on iguana delicatissima from the lesser Antilles: the presence of antibiotic resistant enterobacteria 169
Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece 162
Characterization of a multiresistance plasmid carrying the optra and Cfr resistance genes from an enterococcus faecium clinical isolate 153
Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin 151
CTX-M-type β-lactamases: A successful story of antibiotic resistance 140
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii 140
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 140
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 136
Characterization of Tn6349, a novel mosaic transposon carrying poxtA, cfr and other resistance determinants, inserted in the chromosome of an ST5-MRSA-II strain of clinical origin 133
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 128
A dirty job: dishwasher wastewater reuse and upcycle through an ad hoc engineered microbial consortium 125
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 125
DNABII targeting antibodies as vaccines against biofilm diseases 123
Characterization of bacteriophages with lytic activity for major clones of KPC-producing Klebsiella pneumoniae. 122
Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions 120
Application of bacteriophages for human health: an old approach against contemporary “bad bugs” 120
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 118
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 118
CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy 116
Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid 115
Bioactive liposomes for the control of Mycobacterium abscessus infection. 115
Characterization of a novel putative Xer-dependent integrative mobile element carrying the blaNMC-A carbapenemase gene, inserted into the chromosome of members of the Enterobacter cloacae complex 113
The seagrass holobiont: what we know and what we still need to disclose for its possible use as an ecological indicator 113
Acquired AmpC type beta-lactamases: An emerging problem in Italian long-term care and rehabilitation facilities 112
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 112
Lytic bacteriophages against KPC-KP and their efficacy in a preclinical model. 109
Genomic epidemiology of carbapenem- and colistin-resistant Acinetobacter baumannii from Greece 108
Molecular and physiological characterization of a new lytic bacteriophage against KPC-positive Klebsiella pneumoniae. 107
A phototrophic/heterotrophic microbial consortium able to reuse and upcycle dishwasher wastewater in Zero-Mile food production 104
Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge 104
Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor 104
Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management 104
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 103
Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions 103
Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase 103
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 102
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy 98
Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae 98
Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in Northern Italy 97
Complete genome sequence of the first KPC-type carbapenemase-positive Proteus mirabilis strain from a bloodstream infection 96
Uncovering the Fungal Community Composition of Alive and Dead Posidonia oceanica Matte 95
Phosphaditylserine liposomes as a possible candidate for the therapeutic management of Mycobacterium abscessus infection in CF patients 94
Draft genome sequence of the first hypermucoviscous Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a bloodstream infection 94
Effects of selective digestive decontamination (SDD) on the gut resistome 94
Microbial consortia in wastewater treatment and up-cycling. 92
MgrB inactivation is a common mechanism of colistin resistance in KPC-producing klebsiella pneumoniae of clinical origin 91
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 89
Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: Report on the first Italian cases 89
A Helping Hand: Fungi, as Well as Bacteria, Support Ecophysiological Descriptors to Depict the Posidonia oceanica Conservation Status 88
Mining microbial metatranscriptomes for expression of antibiotic resistance genes under natural conditions 88
The spread of CTX-M-type extended-spectrum β-lactamases 87
Home Sweet Home: Setting the Best Thriving Conditions for the Ad Hoc Engineered Microbial Consortium in the Zero Mile System 86
Isolation of Klebsiella pneumoniae strains with altered susceptibility to carbapenems not carbapenemase mediated 86
pHTβ-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis 85
Plasmid-mediated or chromosomally mediated colistin resistance in Klebsiella pneumoniae? 84
Draft genome sequence of Proteus mirabilis NO-051/ 03, representative of a multidrug-resistant clone spreading in Europe and expressing the CMY-16 AmpC-type β-lactamase 84
Diversity of capsular polysaccharide gene clusters in Kpc-producing Klebsiella pneumoniae clinical isolates of sequence type 258 involved in the italian epidemic 84
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator 84
In vivo evolution to Colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment 82
Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review 81
Diversity and Composition of Posidonia oceanica-Associated Bacterial and Fungal Communities: Effect of Boat-Induced Mechanical Stress in the Villefranche-sur-Mer Bay (France) 79
Linezolid-resistant cfr-positive MRSA, Italy 79
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases 78
Management of meningitis caused by multi drug-resistant Acinetobacter baumannii: Clinical, microbiological and pharmacokinetic results in a patient treated with colistin methanesulfonate 78
Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe 77
Large oligoclonal outbreak due to klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 76
Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases 76
DNA microarray for detection of macrolide resistance genes 74
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane-tazobactam and comparators, and molecular epidemiology of carbapenemase producers. 73
Newborn bacteraemia caused by an Aeromonas caviae producing the VIM-1 and SHV-12 β-lactamases, encoded by a transferable plasmid 70
OXA-372, a novel carbapenem-hydrolysing class D β-lactamase from a Citrobacter freundii isolated from a hospital wastewater plant 70
Galleria mellonella for assessing the efficacy of monoclonal antibodies against Staphylococcus aureus 69
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis 68
The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model 66
Evaluation of the KPC K-SeT™ immunochromatographic assay for the rapid detection of KPC carbapenemase producers from positive blood cultures 66
Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase 65
Totale 15.503
Categoria #
all - tutte 62.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/20221.134 54 114 44 10 62 71 77 145 74 63 96 324
2022/20231.332 141 118 97 140 85 330 123 66 113 18 55 46
2023/20241.802 89 35 49 249 190 392 221 184 91 93 98 111
2024/20253.191 169 436 295 203 154 212 373 190 374 253 271 261
2025/20265.383 395 222 532 378 340 212 693 642 549 493 665 262
Totale 16.438